7.3 Staff Investigators Within the UCSF Helen Diller Family Comprehensive Cancer Center are investigators who perform key roles in the activities of the Center, but are not specifically represented in our senior leader or programmatic line-up. Our Staff Investigators make sure that we, as a Center, are at the cutting edge of specific research areas that we believe will be important growth areas and opportunities in the future. Staff Investigators attend our quarterly off-site retreats, and report to the other members ofthe Center's leadership on new developments in these areas. In this application, we propose five of these individuals for funding: Celia Kaplan, Ph.D., Coordinator, Inreach Dr. Kaplan's research is in the field of health disparities and cancer prevention and control, as well as in conducting epidemiologic, health services, and communication research, with an emphasis on cancer care disparities. Her work has focused on assessing individual, community, and system factors associated with health access, and in factors affecting participation in clinical trials among patients, physicians, and community organizations. This expertise has led to the work she initiated, and will pursue as Staff Investigator. Dr. Kaplan partnered with Dr. Eric Small, Deputy Director and Associate Director of Clinical Sciences and of the Investigational Trials Resource (ITR), to evaluate the patterns of accrual to clinical trials at the Center. Overall accrual of minority and underserved populations (relative to the distribution of new cases seen at the Center, and relative to several catchment areas), and the relative contributions of outreach and inreach were evaluated. The results from this work led to the decision to specifically build an inreach effort in the Center. Dr. Kaplan will direct this initiative as part of her role as a Staff Investigator. Dr. Kaplan has established a center-wide initiative entitled,

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of California San Francisco
San Francisco
United States
Zip Code
Chen, Justin; Weiss, William A (2014) When deletions gain functions: commandeering epigenetic mechanisms. Cancer Cell 26:160-1
Johnson, Brett E; Mazor, Tali; Hong, Chibo et al. (2014) Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma. Science 343:189-93
Witte, John S; Visscher, Peter M; Wray, Naomi R (2014) The contribution of genetic variants to disease depends on the ruler. Nat Rev Genet 15:765-76
Sufiawati, Irna; Tugizov, Sharof M (2014) HIV-associated disruption of tight and adherens junctions of oral epithelial cells facilitates HSV-1 infection and spread. PLoS One 9:e88803
Sharma, Vineeta; Witkowski, Andrzej; Witkowska, H Ewa et al. (2014) Aberrant hetero-disulfide bond formation by the hypertriglyceridemia-associated p.Gly185Cys APOA5 variant (rs2075291). Arterioscler Thromb Vasc Biol 34:2254-60
Gustafson, William Clay; Meyerowitz, Justin Gabriel; Nekritz, Erin A et al. (2014) Drugging MYCN through an allosteric transition in Aurora kinase A. Cancer Cell 26:414-27
Gable, Jonathan E; Lee, Gregory M; Jaishankar, Priyadarshini et al. (2014) Broad-spectrum allosteric inhibition of herpesvirus proteases. Biochemistry 53:4648-60
Cope, Leslie M; Fackler, Mary Jo; Lopez-Bujanda, Zoila et al. (2014) Do breast cancer cell lines provide a relevant model of the patient tumor methylome? PLoS One 9:e105545
Bankoti, Jaishree; Apeltsin, Leonard; Hauser, Stephen L et al. (2014) In multiple sclerosis, oligoclonal bands connect to peripheral B-cell responses. Ann Neurol 75:266-76
Ilkanizadeh, Shirin; Lau, Jasmine; Huang, Miller et al. (2014) Glial progenitors as targets for transformation in glioma. Adv Cancer Res 121:1-65

Showing the most recent 10 out of 71 publications